Daracuro combination subcutaneous injection (Daratumumab・Borhyaluronidase alpha), from Janssen Pharmaceutical (YJ code: 4291500A1023, standard: 15mL bottle), is used to treat multiple myeloma and light chain amyloidosis. This combination medication helps slow or stop cancer cell growth and enhances the absorption of other medicines.
Daracuro combination subcutaneous injection
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →